Teknova, a manufacturer of cell culture media, protein purification buffers, and molecular biology reagents, has completed the US Food and Drug Administration (FDA) notification process for its CDC formulation Viral Transport Medium (VTM).
The current pandemic has led to unparalleled pressure on laboratories to ramp up capacity for SARS-CoV-2 testing. INTEGRA’s electronic pipettes, pipetting robots and other instruments have helped many laboratories tackle this challenge.
The SARS-CoV-2 pandemic is one of the most urgent infectious disease challenges the world has faced in recent history. As few treatment options exist, the need to evaluate neutralising antibodies to fight the virus is at an all-time high.
A rapid new coronavirus test, which provides results in just 39 minutes, is now available on the Vivalytic, a point-of-care platform brought to market by Randox Laboratories and Bosch.
EKF Diagnostics has announced that the viral transport medium PrimeStore MTM (Molecular Transport Medium) has been successfully evaluated for effective SARS-CoV-2 inactivation in a new study published by Public Health England.
A Dundee-based biomedical scientist has won the 2020 Bernie Benson Prize for his science writing. The competition sought to promote the understanding and exploration of blood viscosity testing.
PCR Biosystems has launched RiboShield RNase Inhibitor, a robust and reliable RNase inhibitor that is now available as a standalone product.
Teknova, a manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, has responded to the SARS-CoV-2 pandemic by significantly scaling up production of Viral Transport Medium (VTM) and saline.
Avacta Group, the developer of Affimer biotherapeutics and reagents, has entered an agreement with Abingdon Health for the manufacture of its saliva-based rapid SARS-CoV-2 antigen test as part of an ongoing expansion of manufacturing capacity.
Avero Diagnostics, a physician-owned US laboratory, has announced the expansion of its COVID-19 testing portfolio with the addition of the Roche Elecsys anti-SARS-CoV-2 antibody test.
Edinburgh-based biotechnology company Ingenza has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current pandemic and COVID-19 disease.
Hercules Pharmaceuticals has announced the publication of promising preclinical in vivo trial results showing efficacy of its aryl hydrocarbon receptor (AhR) inhibitor HP163 against Zika virus infection and potentially against coronavirus.
Remarkable things are happening as laboratories and anatomical pathology groups answer the challenges of the SARS-CoV-2 pandemic and the need for greater numbers of virus tests. Despite shortages, laboratories are adding SARS-CoV-2 test capacity.
PrimeStore MTM is a molecular transport medium that provides a ‘snapshot’ in time of a sample by preserving and stabilising DNA and RNA. This means that samples can be collected, transported, and processed safely and efficiently.